Aclarion, Inc. Overview
Pro stress-test →Aclarion operates as a healthcare technology company that uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine.
Strategic Profile
Pro stress-test →Aclarion offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that processes MRS exam data into final spectra and performs degenerative pain biomarker calculations, and NOCIGRAM, which processes results into NOCISCORES on a 0-10 scale. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for scanning intervertebral discs which extends the time of a standard lumbar MRI exam, and imaging data transfer products including AMBRA Healthcare.
Competitive Landscape
Pro stress-test →Aclarion operates in the specialty diagnostic imaging and pain management technology space with limited direct competitors offering MRS-based spinal biomarker analysis. Broader competitors include general orthopedic diagnostics companies and pain management technology providers. The company's NOCISCAN platform represents a differentiated approach to identifying degenerative disc disease biomarkers.
Industry Context
Aclarion, Inc. operates in Healthcare Technology / Medical Diagnostics.
Key facts
Founded: 2008 · Headquarters: Broomfield, Colorado · Employees: N/A · Revenue: N/A · Market cap: $7.6M